Fetal Monitoring Equipment Market Witness Excellent Revenue Growth During 2024-2030: Grand View Research Inc

Posted by Sona Kulkarni on November 29th, 2024

Fetal Monitoring Equipment Market Growth & Trends

The global fetal monitoring equipment market size is anticipated to reach USD 6.16 billion by 2030 and is anticipated to expand at a CAGR of 9.02% during the forecast period, according to a new report by Grand View Research, Inc. The market is driven by the increasing government initiatives that are aimed at reducing infant mortality rates. Governments are investing heavily in improving healthcare infrastructure, particularly in maternal and neonatal care. Initiatives such as the United Nations Sustainable Development Goals (UNSDGs), specifically targeting a reduction in infant mortality, have prompted government investments in fetal monitoring devices. These programs emphasize improving access to maternal healthcare and advanced medical technologies. In addition, many nations have increased funding for hospitals, clinics, and maternal health centers, often requiring fetal monitoring equipment as a standard feature in obstetric wards. This demand for improved neonatal care, induced by government-backed funding programs.

Moreover, several innovations have emerged, and initiatives are being undertaken, highlighting the potential for more effective monitoring of fetal health. For instance, in September 2023, the RADx Tech Fetal Monitoring Equipment Challenge was launched by the National Institutes of Health (NIH) in partnership with the Bill & Melinda Gates Foundation. The challenge's goal was to speed up the development of diagnostic and monitoring technologies. More than 40 entries was submitted by different innovators, focusing on creating affordable and accessible solutions for monitoring fetal health, especially in low-resource environments.

Furthermore, AI and machine learning are being integrated into fetal monitoring systems to improve data processing and interpretation. These technologies can help in noise suppression, feature detection, & fetal state classification, thereby reducing false positives and enhancing the reliability of monitoring outcomes. For instance, the Lullaby algorithm, developed by researchers at UC Irvine in 2022, effectively distinguishes fetal heartbeats from maternal signals, improving the accuracy of readings.

Request a free sample copy or view report summary: Fetal Monitoring Equipment Market Report

Fetal Monitoring Equipment Market Report Highlights

• Based on product, the fetal monitors segment held the largest revenue share in 2023. The growth of this segment is attributed to the growing awareness about the importance of monitoring fetal health, along with an increase in preterm births and fetal issues.
• Based on application, the antepartum segment held the largest revenue share of in 2023. The growing governmental and non-governmental organizations' initiatives aimed at reducing infant mortality rates and improving prenatal care standards have significantly contributed to the expansion of the antepartum segment.
• Based on portability, the non-portable segment held the largest revenue share in 2023. However, portable segment is anticipated to grow at the fastest growth rate over the forecast year.
• Based on type, the non-invasive segment held the largest revenue share of in 2023 and is anticipated to grow at the fastest growth rate over the forecast year.Key drivers contribute to the dominance of non-invasive fetal monitoring.
• Based on end use, the hospitals segment held the largest revenue share of in 2023 and is anticipated to grow at a fastest growth rate over the forecast year.
• North America region held the largest market share in 2023, as companies continuously launching new products and solutions to meet the evolving needs of healthcare providers.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-fetal-monitoring-equipment-market

Fetal Monitoring Equipment Market Segmentation

Grand View Research has segmented the global fetal monitoring equipment market on the basis of product, application, portability, type, end-use, and region:

Fetal Monitoring Equipment Product Outlook (Revenue, USD Million, 2018 - 2030)

• Fetal Monitors
• Fetal Doppler Devices
• Ultrasound Devices
• Fetal Transducer
• Telemetry Devices
• Accessories and Consumables

Fetal Monitoring Equipment Application Outlook (Revenue, USD Million, 2018 - 2030)

• Antepartum
• Intrapartum

Fetal Monitoring Equipment Portability Outlook (Revenue, USD Million, 2018 - 2030)

• Non-Portable
• Portable

Fetal Monitoring Equipment Type Outlook (Revenue, USD Million, 2018 - 2030)

• Non-Invasive
• Invasive

Fetal Monitoring Equipment End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals
• Clinics
• Others

Fetal Monitoring Equipment Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Norway
  • Denmark
  • Sweden
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand 
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

List of Key Players in the Fetal Monitoring Equipment Market

• Avante Health Solutions
• Bionet America, Inc.
• CooperSurgical Inc. (THE COOPER COMPANIES, INC.)
• EDAN Instruments, Inc.
• FUJIFILM India Private Limited
• GE Healthcare
• Koninklijke Philips NV
• MEDGYN PRODUCTS INC.
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
• Siemens Healthineers
• TRISMED Co., Ltd.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.